• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 5 Jun

    Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

    - Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization… Read More..

    Share this:
  • 1 Jun

    Asensus Shares First Quarter Results and Future Plans

    NEW YORK, NY - (NewMediaWire) - June 1, 2023 - PCG Digital --Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery(TM), recently shared notable operating and financial results for Q1 2023 and… Read More..

    Share this:
  • 30 May

    SS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones

    Company’s flagship SSi Mantra surgical robotic system utilized to perform successful complex cardiac, lung, head and neck surgeries SSi Mantra used in first pediatric urology surgery Robotic surgical system has now completed more than 200 surgeries; clinically validated in India to perform more than 30 different types of surgical procedures Fort… Read More..

    Share this:
« Previous 1 … 143 144 145 146 147 … 235 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact